Antibody therapies for treatment of non-severe COVID-19
Intern Emerg Med
.
2022 Apr;17(3):883-885.
doi: 10.1007/s11739-022-02959-1.
Epub 2022 Mar 16.
Authors
Katie Gourlay
1
,
Nicholas Taylor
2
,
Eddy Lang
3
Affiliations
1
Faculty of Medicine, The University of Alberta, Edmonton, AB, Canada.
[email protected]
.
2
Faculty of Medicine, The University of Alberta, Edmonton, AB, Canada.
3
Department of Emergency Medicine, The University of Calgary, Calgary, AB, Canada.
PMID:
35292911
PMCID:
PMC8923826
DOI:
10.1007/s11739-022-02959-1
No abstract available
MeSH terms
Antibodies, Viral
COVID-19 Drug Treatment*
Humans
SARS-CoV-2
Substances
Antibodies, Viral